The Enzyme Immunoassay (EIA) market is a subset of the In Vitro Diagnostics (IVD) field, which encompasses a wide range of laboratory-based tests used to detect and quantify substances such as proteins, hormones, and antibodies in blood or other biological samples. EIAs, also known as enzyme-linked immunosorbent assays (ELISAs), utilize enzyme-labeled antibodies or antigens to produce a detectable signal, which is proportional to the amount of target analyte present in the sample. This technology is widely employed in clinical laboratories for its specificity and sensitivity in disease diagnosis, monitoring of therapy, and ensuring blood safety. EIAs are also used in food safety testing and research applications. Advancements in automation, monoclonal antibody technology, and the introduction of multiplex assays have expanded the capabilities and applications of EIAs in the IVD industry. In the Enzyme Immunoassay market, several key players provide a spectrum of EIA reagents, kits, and instrumentation. Prominent entities include Abbott Laboratories, Bio-Rad Laboratories, and Siemens Healthineers, all of which have a strong presence in IVD technologies. Other notable companies are Ortho Clinical Diagnostics, Roche Diagnostics, and Danaher Corporation, which operate under various brand names, offering a range of diagnostic solutions that cater to clinical and research needs across myriad health-related fields. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
